Conventional photon radiation therapy dose-calculation algorithms typically compute and report the absorbed dose to water (D w ). Monte Carlo (MC) dosecalculation algorithms, however, generally compute and report the absorbed dose to the material (D m ). As MC-calculation algorithms are being introduced into routine clinical usage, the question as to whether there is a clinically significant difference between D w and D m remains. The goal of the current study is to assess the differences between dose-volume indices for D m and D w MC-calculated IMRT plans. Ten head-and-neck (H&N) and ten prostate cancer patients were selected for this study. MC calculations were performed using an EGS4-based system. Converting D m to D w for MC-based calculations was accomplished as a post-MC calculation process. D w and D m results for target and critical structures were evaluated using the dose-volume-based indices. For H&N IMRT plans, systematic differences between dose-volume indices computed with D w and D m were up to 2.9% for the PTV prescription dose (D 98 ), up to 5.8% for maximum (D 2 ) dose to the PTV and up to 2.7% for the critical structure dose indices. For prostate IMRT plans, the systematic differences between D w -and D m -based computed indices were up to 3.5% for the prescription dose (D 98 ) to the PTVs, up to 2.0% for the maximum (D 2 ) dose to the PTVs and up to 8% for the femoral heads due to their higher water/bone mass stopping power ratio. This study showed that converting D m to D w in MC-calculated IMRT treatment plans introduces a systematic error in target and critical structure DVHs. In some cases, this systematic error may reach up to 5.8% for H&N and 8.0% for prostate cases when the hard-bone-containing structures such as femoral heads are present. Ignoring differences between D m and D w will result in systematic dose errors ranging from 0% to 8%.
Introduction
Conventional photon dose-calculation algorithms (e.g., ETAR, Clarkson, pencil beam, superposition/convolution) traditionally compute and report the absorbed dose as if it were deposited in water; this is referred to as dose to water (D w ). This reporting in terms of D w is due to the fact that the input data for treatment-planning system (TPS) commissioning are measured and computed in water, and, thus, the algorithm parameters are varied such that the calculations best match the water-based measurements. Moreover, the accelerators are calibrated in terms of dose to water since dosimetry calibration protocols are based on absorbed dose to water (AAPM TG-51 and IAEA protocols) (Almond et al 1999 , Huq et al 2001 . For kernel-based approaches, water kernels are computed and density scaling is used, but water is still presumed. This approach is a reasonable first approximation, since the bulk of the patient body (65%) consists of water, though many other tissue types are present. Note that in kernel-based approaches, material kernels (instead of water) may be computed at the expense of computing time (Papanikolaou et al 1993) .
In Monte Carlo (MC)-based patient-dose calculations, however, particle transport simulations occur in a material that is representative of the underlying tissues; thus, materialspecific interactions are taken into account, and absorbed dose is generally tallied into the representative material or dose to material (D m ) rather than the absorbed dose to the water (D w ). Siebers et al (2000a) reasoned that there may be circumstances when both conversions to water and medium are desired and developed a procedure that uses an energy-dependent stopping power ratio, S w,m , that converts D m to D w , based upon the Bragg-Gray cavity theory for MC-based calculations for external beam photon radiation therapy. The methods to best perform this conversion were further discussed in a letter to the editor (Fippel and Nusslin 2000) and a subsequent reply (Siebers et al 2000c) .
In a point-counterpoint discussion, Liu (Keall and Liu 2002) argued that the rationale for converting D m back to D w is driven solely by the desire to comply with tradition and that this conversion process not only adds uncertainty to the calculations, but also defeats the purpose of using MC. Liu (Keall and Liu 2002 ) also stated that the clinical impact of switching from D w to D m should not be significant, since most tissues in the human body are similar. In the same point-counterpoint discussion, Keall (Keall and Liu 2002) stated that traditional clinical experience has been based on D w -based dose calculations and that this is a reasonable approach, since water makes up the bulk of the cells and tissues in the human body. He also stated that modern dosimetry protocols (e.g., AAPM TG-51 (Almond et al 1999) and International Atomic Energy Agency (Huq et al 2001) ) are still based on D w and that it is reasonable to report TPS dose calculations that are directly traceable to the calibration. Keall (Keall and Liu 2002) also argued that the CT numbers that are used in MC treatment planning and converted to medium are generally obtained from ICRU or ICRP publications, even though it is not known if a specific organ from an individual patient has exactly the same composition as the 'standard' organ. Therefore, there will always be errors present in specifying the medium for the dose calculation, and the magnitude of this material assignment error may, in fact, be decreased with the D w conversion.
Previous investigators (Siebers et al 2000a , Ma et al 1999 did not address the effects of D w to D m conversion on a significant number of patients. Siebers et al (2000a) described a method that converts D m to D w and showed a H&N plan example. Ma et al (1999) described a clinical implementation of their MC TPS and presented the correction factors as the ratio of D m to D w in a heterogeneous phantom. They stated that the convolution/superposition methods report dose to water, and, therefore, that the comparisons of the correction factors in heterogeneous regions cannot be made directly without properly converting the dose to the same medium.
Regardless of whether D w or D m is the most appropriate value to report for MC dose computation, it is important to know how much they differ so that the importance of this conversion can be judged for clinical cases. The purpose of this study was to evaluate the differences in target and critical structure doses if D w or D m is used in the dose evaluation of MC-based dose calculations for a large set of IMRT patients.
Methods
Ten patients with H&N cancer and ten patients with prostate carcinoma were selected for this study. 6 MV and 18 MV photon beams were used for the IMRT planning of the H&N and prostate cases, respectively. IMRT optimization was performed using an in-house-developed system that is interfaced with the Pinnacle 3 TPS. The details of the functionality of this system have been discussed elsewhere (Wu and Mohan 2000) . The MC algorithm was used to calculate the dose for all of the plans. The MC calculations were performed using the EGS4 user code (Nelson et al 1985 (Nelson et al , 1988 , BEAM (Rogers et al 1995) , for the treatment-head simulation, including transport through the MLC to simulate the dynamic IMRT delivery (Siebers et al 2002) and DOSXYZ (Ma et al 1995) for the patient dose calculation. This MC system (Siebers et al 2000b , Arnfield et al 2000 is fully integrated with the Pinnacle 3 TPS (Philips Laboratories, Milpitas, CA). The details of our MC algorithm have been previously discussed (Siebers et al 2002 , 2000b , Arnfield et al 2000 , Keall et al 2001 , and it has been well benchmarked for IMRT.
A nominal value of 2% of the maximum dose statistical uncertainty per beam was used for all MC dose calculations, leading to a <1% statistical uncertainty in the dose to the targeted tissues. It has been previously shown that an overall 2% statistical uncertainty has minimal effect on DVHs, and these statistics are sufficient for dose-volume analysis (Jeraj and Keall 2000, Keall et al 2000) . Structure-by-structure analysis of the statistical uncertainty in the dose for one of the H&N and prostate patients included in this study is shown in figure 1 , demonstrating that the statistical uncertainty in dose to the targets and critical structures is <1.0% and <1.5% for the H&N and prostate cases, respectively. The uncertainty in DVHevaluated parameters, however, will be <1.0%.
The conversion from D m to D w in MC calculations was performed using the post-MC calculation methods that utilized the Bragg-Gray cavity theory (Bragg 1950) . The details of this method have been described in Siebers et al (2000a) and are summarized here for completeness. Although other methods, such as performing the conversion during MC simulation rather than in the post-processing, can be used to convert D m to D w , it has been previously shown by Siebers et al (2000a) that the post-processing method is valid for photon beams. Moreover, this method can be used with other dose-calculation algorithms, such as convolution/superposition or pencil beam to convert the dose to water to dose to medium. Using the Bragg-Gray cavity theory, D w is related to the D m by
where S w,m is the unrestricted water-to-medium mass collision stopping power ratio averaged over the energy spectra of primary electrons put into motion from photon interactions. Siebers et al (2000a) determined that S w,m has weak energy dependence at MeV energies and the electron spectra throughout a treatment volume are relatively constant. Thus, S w,m is nearly independent of the depth of the point of interest in the phantom
• whether the point of interest is inside or outside the radiation field, and • the material in which the electron spectra were generated.
Hence, a photon energy and material-dependent S w,m conversion factor could be used with a <1.1% error (Siebers et al 2000a) provided that sufficient materials are included in the conversion process (Siebers et al 2000a, Fippel and Nusslin 2000) . The water-to-material stopping power ratios for the materials used in our clinical MC application (and this work) for both the 6 MV and 18 MV beams are shown in figure 2.
For the H&N cases evaluated in this work, the target volumes consisted of PTV GTV , PTV CTV and PTV Nodes . For prostate cases, the target volumes were PTV Prostate and PTV Nodes . The critical structures for the H&N cases included the spinal cord, brainstem, parotid glands and larynx. The critical structures for the prostate cases were the rectum, bladder, small bowel and femoral heads. The MC-calculated plans (computed with D m and converted to D w ) were evaluated using the dose-volume-based indices: minimum doses received by 2% and 98% of the target volumes (D 2 and D 98 ), doses to the 2% and 50% (D 2 and D 50 ) of the normal structure volumes and mean doses to the normal structures (D mean ). The D m -and D w -based isodose distributions and DVHs for one of the H&N and one of the prostate cases are also presented to demonstrate the effect of applying the D m conversion factors.
Results
This paper reports on the dosimetric differences of the MC-calculated IMRT plans when D w or D m is used in the dose evaluation for ten H&N and ten prostate cancer patients. This study showed that converting D m to D w in MC-calculated IMRT treatment plans introduces a systematic error in target and critical structure DVHs. The isodose distributions through a transverse patient slice and DVHs for D m -and D w -based computations for one of the H&N IMRT plans are shown in figure 3. As shown in figures 3(a) and (b), the 50 Gy isodose line (CT scans on second row) varies noticeably between the two dose distributions. While the 50 Gy isodose line misses the brainstem for the D m plan, the 50 Gy isodose line touches the brainstem for the D w plan (note that the stopping power ratio for brainstem for this patient was 1.012). Moreover, the 54 Gy line lies noticeably distant from the brainstem for the D m -based plan, while it is very close to the brainstem for the D w -based plan. The cause of this systematic shift in the bone above the brainstem is due to the fact that for bone, S w,m is greater than 1. As seen in figures 3(a) and (b), while both the 70.8 Gy and the 60.0 Gy isodose lines (CT scans on first row) extend well into the mandible for the D w -based plan, they are noticeably distant from the mandible for the D m -based plan. The cause of this isodose line shift is due to the fact that the target volumes infiltrate the mandible. Figure 3(c) shows that converting from D m to D w systematically shifts the resulting DVHs for the target volumes by about 1.5% and for the critical structures by about 1%. This is due to the fact that the materials in these H&N cases are primarily tissue, and this corresponds with the stopping power ratios of the underlying tissues. one patient in whom this shift was 3.5% due to the involvement of high-density bone content in the nodal volume. For the rectum, bladder and small bowel, the systematic shift in the D 2 index was <1% for all patients. For femoral heads, however, the systematic shifts, ranging from 4.0% to 8.0% in (D w /D m ) D 2 were observed ( figure 8(a) ). This was due to the high calcium content of the bones, which increased the water-to-material stopping power ratio due to the increased neutron/proton ratio in calcium relative to water (caused by the hydrogen content of water). As shown in figure 8(c), there was a <1% systematic shift in the D mean for the rectum, bladder and small bowel, except for the femoral heads in which an increase up to 6.2% in D w -based D mean occurred as compared with the D m -based MC calculation. Note that although the individual material dose-conversion factors in figure 2 exceeded 10%, the DVHs do not show such large differences because the majority of the materials (in the 20 patients that were analysed) were soft-tissue like. In this work, we distinguished the individual materials on an individual voxel-by-voxel basis, which was the basis of the D w to D m conversion method. Thus, the effects in bone, air and each and every patient material were fully observed. In fact, the voxel-to-voxel basis comparisons reveal the material-dependent stopping power ratios (figure 2). The display of the results on a voxel-by-voxel basis for each structure and patient, however, were not presented, because clinically, this is how these dose differences, for the sum of the voxels contained in a region of interest (ROI), combine to form the DVH that is clinically important. Air and bone dose voxels, if included in the ROIs, have their dose values increased in the D m to D w conversion. This may be of particular concern for ROIs (e.g., PTVs) which extend into air cavities. However, we have made no attempt to override materials and instead directly used the conversion. Although it may be interesting to present the details of the medium definition and dose conversion for each target for each patient (and looking for the voxel with the maximum change), the clinical endpoint of this analysis is how the conversion affects the resulting dose distribution and DVHs since the clinical decisions by physicians are based on doses and DVHs.
Discussion
Treatment planning employing conventional dose-calculation algorithms reports the absorbed dose to the water, D w . In treatment planning utilizing the MC techniques, however, the absorbed dose can be reported in terms of the absorbed dose to medium, D m , or in terms of D w . The reporting, D w versus D m , in MC treatment planning is still a controversial topic, and there are proponents and opponents of each argument. The proponents of the use of D m argue that the rationale for converting D m back to D w is driven simply by the desire to comply with tradition and that this conversion process not only adds uncertainty to the calculations, but also defeats a potential advantage of using MC. Similarly, the supporters of D w argue that reporting D m in MC treatment planning is an estimation process, because of the uncertainties caused by specifying that the medium necessary for dose calculation and all clinical experience is MC-calculated IMRT treatment plans introduces systematic errors in target and critical structure DVHs. For H&N cases, these systematic errors may reach up to 5.8% for PTVs and up to 2.7% for critical structures. For prostate cases, the systematic errors ranged from −0.5% to 3.5% for targets and reached up to 8% for critical structures, especially when hardbone-containing structures such as the femoral head volumes intersect with a critical structure volume.
The use of D m in treatment planning is likely to change the current prescription doses since all clinical experience and prescription doses reported in past and current clinical trials are presented within terms of D w . The change in prescription doses is not expected to be significant since most tissues in the human body are similar to water. However, evaluation of whether D w or D m should be used for dose prescription and evaluation for MC-based treatments, i.e., which is more closely related to clinical outcomes, remains to be determined.
Regardless of whether D w or D m is the most appropriate value to report for MC dose computation, one should be aware of the systematic errors in calculated dose distributions introduced by converting D m to D w . For our IMRT quality-assurance program, we routinely compare the D w -based superposition-calculated dose with the MC-calculated dose distributions. For consistency, we convert our MC results to D w prior to comparison for our IMRT patient plans.
Conclusion
Converting from D m to D w in MC-calculated IMRT treatment plans introduces systematic errors in target and critical structure doses. Currently, we have no clinical outcome data comparing both methods and until either D w or D m is shown to correlate more closely with clinical outcome, the arguments for and against D w or D m should be considered in determining which method a user should choose to implement on a routine clinical basis. For consistency, however, D m to D w conversion should be available when comparing MC-calculated treatment plans with the plans computed with conventional D w -based algorithms.
